Listen "Nested, Cellarity, Replimune, Estrella"
Episode Synopsis
Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPACFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesNested TherapeuticsCellarityReplimuneEstrella BiopharmaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
More episodes of the podcast Life Science Today
Final Episode
20/12/2022
Intellia, Regeneron, Viatris + Oyster Point
15/11/2022
Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye
02/11/2022
FDA, AbbVie + DJS, Roche + Hookipa, Kyverna
25/10/2022
DICE, Odyssey, Fred Hutch, Merck (MSD)
18/10/2022
Eisai + Biogen, Amylyx, Sanofi + Regeneron
04/10/2022
Alnylam, Intellia, Third Harmonic, Galvanize
20/09/2022
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.